The COVID-19 pandemic continues to evolve and impact our personal and professional lives. We want to assure our trustees, reviewers, and grantee communities that our TMF staff continues to provide high quality biomedical research grantmaking services. We will do our part to help manage any potential challenges and continue supporting research to the extent that it is possible. Please notify us with any questions or requests.
ADDRESSING THE LEADING CAUSE OF BLINDNESS IN OLDER ADULTS
The Edward N. & Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct service projects and medical research on diseases and disorders affecting older adults. In keeping with the Foundation’s mission, the goal of the Awards Program is to support translational research that will lead to improved therapies for individuals suffering from age-related macular degeneration (AMD).
Successful research proposals will extend recent basic research findings regarding the underlying mechanisms of AMD. Examples of funding areas include, but are not limited to, genetically engineered animal models, the discovery and testing of small molecule therapies directed at promising targets including immune-, inflammation-, or lipid-related pathways associated with AMD, local drug delivery systems, and neuroprotective strategies. Basic research and clinical trials are outside the scope of this Program. However, clinical studies that involve the evaluation of new imaging modalities with no potential risks to human subjects are eligible.
Sign up to be added to the Thome Memorial Foundation distribution list
